CleanCap® - optimized co-transcriptional capping for vaccine and therapeutic applications.
Achieve optimal capping results.
Learn More
Accelerate mRNA production with maximum efficiency.
Get Ready to Scale UpCleanCap® mRNA for rapid vaccine development and top-tier oligos to power diagnostic kits
Contact Us for Immediate ResponseWe offer custom plasmid DNA production services, as well as enhanced scale-up manufacturing of CleanCap® mRNA capping solutions and small molecules.
Learn moreTriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.
Achieve optimal capping results.
Learn More
Hilton Boston Logan Airport, Boston, MA, USA
July 26, 2022 - July 28, 2022
Robust service offerings, with the phases and support you need to see your project to completion.
Learn MoreDual antigen self-amplifying RNA vaccines promise enhanced protection against SARS-CoV-2
Learn MoreIL-1 and IL-1ra Regulate the Inflammatory Response to RNA Vaccines
Learn MoreIn Vivo Production of CAR T Cells Promises to Treat Cardiac Injury
Learn MoreThe TriLink Education Center is an innovation resource hub. Read the latest in technical articles, research updates, publications, and more.
Learn More